Approximately 85–90 % of cancer cells use the ribonucleoprotein, telomerase, containing a catalytic subunit (TERT) and an RNA template (TERC) to add sequential TTAGGG telomeric repeats to the ends of chromosomes [8], [9], [10]. The gene discussed is TERT; the disease is cancer.